SGHT — Sight Sciences Share News
0.000.00%
Last trade - 00:00- $287.28m
- $242.86m
- $77.36m
U.S. STOCKS ON THE MOVE-First Solar, Canadian Solar
U.S. STOCKS ON THE MOVE-Zions Bancorp, Neurocrine Biosciences, Beauty Health
U.S. STOCKS ON THE MOVE-Guardforce AI, 2seventy Bio, GoDaddy
Sight Sciences tumbles on lowering annual revenue forecast
U.S. RESEARCH ROUNDUP-Block, Caretrust REIT, Sight Sciences
Brief: Sight Sciences Q2 Revenue USD 23.5 Million Vs. IBES Estimate USD 22.4 Million
Brief: Sight Sciences Reaffirms FY Revenue View Of $89 Mln To $94 Mln
Brief: Sight Sciences Says WPS Government Health Administrators Filed Proposed Local Coverage Determination On Micro-Invasive Glaucoma Surgery
Brief: Sight Sciences Q1 revenue USD 18.8 million
Brief: Sight Sciences Defeats 4 Patent Invalidity Challenges Filed By Alcon
Brief: Sight Sciences Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Brief: Sight Sciences Reports Q4 And Full Year 2022 Financial Results
Brief: Sight Sciences Q4 revenue USD 20.5 million
Sight Sciences dips as CFO steps down
Brief: Verana Health And Sight Sciences Collaborate On Glaucoma Research Using Curated Real-World Data From The Iris Registry
Sight Sciences gains on 2022 sales forecast raise
Sight Sciences Inc reports results for the quarter ended in September - Earnings Summary
Brief: Sight Sciences Inc Reports Q3 Revenue Rose 43 Percent To $18.7 Million
Sight Sciences Inc expected to post a loss of 46 cents a share - Earnings Preview